672315 Ursolic Acid - CAS 77-52-1 - Calbiochem

Overview

Replacement Information

Key Specifications Table

Empirical FormulaCAS #
C₃₀H₄₈O₃ 77-52-1

Pricing & Availability

Catalog Number AvailabilityPackaging Qty/Pack Price Quantity
672315-50MG
Retrieving availability...
Limited AvailabilityLimited Availability
Stocked 
Discontinued
Limited Quantities Available
Available
    Remaining : Will advise
      Remaining : Will advise
      Will advise
      Contact Customer Service
      Contact Customer Service

      Glass bottle 50 mg
      Retrieving price...
      Price could not be retrieved
      Minimum Quantity needs to be mulitiple of
      Upon Order Completion More Information
      You Saved ()
       
      Request Pricing
      Description
      OverviewA cell-permeable plant-derived pentacyclic triterpene acid that displays anti-inflammatory, immunomodulatory, and antitumor activities. Shown to inhibit the phosphatase activity of SHP2, PTP1B, and TCPTP (IC50 = 2.73, 3.08 and 3.33 µM, respectively) as well as induce IR autophosphorylation independent of its phosphatase inhibitory activity. Ursolic acid is also reported to inhibit NF-κB and STAT3 pathway activation in cancer cultures, resulting in enhanced sensitivity to chemotherapy agents and apoptotic cell death.
      Catalogue Number672315
      Brand Family Calbiochem®
      Synonyms3β-Hydroxy-urs-12-en-28-oic acid, CG7, PTPN2/TCPTP Inhibitor II, SHP2 Inhibitor IV, PTP1B Inhibitor VII, PTP Inhibitor XXVII
      References
      ReferencesLi, Y., et al. 2010. Int. J. Cancer 127, 462.
      Pathak, A.K., et al. 2007. Mol. Cancer Res. 5, 943.
      Jung, S.H., et al. 2007. Biochem. J. 403, 243.
      Zhang, W., et al. 2006. Biochim. Biophys. Acta 1760, 1505.
      Shishodia, S., et al. 2003. Cancer Res. 63, 4375.
      Product Information
      CAS number77-52-1
      FormWhite powder
      Hill FormulaC₃₀H₄₈O₃
      Chemical formulaC₃₀H₄₈O₃
      Structure formula ImageStructure formula Image
      Quality LevelMQ100
      Applications
      Biological Information
      Purity≥98% by HPLC
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Standard Handling
      Storage +2°C to +8°C
      Protect from Light Protect from light
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 6 months at -20°C.
      Packaging Information
      Packaged under inert gas Packaged under inert gas
      Transport Information
      Supplemental Information
      Specifications

      Documentation

      Ursolic Acid - CAS 77-52-1 - Calbiochem SDS

      Title

      Safety Data Sheet (SDS) 

      Ursolic Acid - CAS 77-52-1 - Calbiochem Certificates of Analysis

      TitleLot Number
      672315

      References

      Reference overview
      Li, Y., et al. 2010. Int. J. Cancer 127, 462.
      Pathak, A.K., et al. 2007. Mol. Cancer Res. 5, 943.
      Jung, S.H., et al. 2007. Biochem. J. 403, 243.
      Zhang, W., et al. 2006. Biochim. Biophys. Acta 1760, 1505.
      Shishodia, S., et al. 2003. Cancer Res. 63, 4375.
      Data Sheet

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision07-December-2010 RFH
      Synonyms3β-Hydroxy-urs-12-en-28-oic acid, CG7, PTPN2/TCPTP Inhibitor II, SHP2 Inhibitor IV, PTP1B Inhibitor VII, PTP Inhibitor XXVII
      DescriptionA cell-permeable plant-derived pentacyclic triterpene acid that displays anti-inflammatory, immunomodulatory, and antitumor activities. Shown to inhibit the phosphatase activity of SHP2, PTP1B, and TCPTP (IC50 = 2.73, 3.08 and 3.33 µM, respectively) as well as induce IR autophosphorylation independent of its phosphatase inhibitory activity. Ursolic acid is also reported to inhibit NF-κB and STAT3 pathway activation in cancer cultures, resulting in enhanced sensitivity to chemotherapy agents and apoptotic cell death.
      FormWhite powder
      Intert gas (Yes/No) Packaged under inert gas
      CAS number77-52-1
      Chemical formulaC₃₀H₄₈O₃
      Structure formulaStructure formula
      Purity≥98% by HPLC
      SolubilityDMSO (50 mg/ml) or Ethanol (3.5 mg/ml)
      Storage +2°C to +8°C
      Protect from light
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 6 months at -20°C.
      Toxicity Standard Handling
      ReferencesLi, Y., et al. 2010. Int. J. Cancer 127, 462.
      Pathak, A.K., et al. 2007. Mol. Cancer Res. 5, 943.
      Jung, S.H., et al. 2007. Biochem. J. 403, 243.
      Zhang, W., et al. 2006. Biochim. Biophys. Acta 1760, 1505.
      Shishodia, S., et al. 2003. Cancer Res. 63, 4375.